NASDAQ:DCPH

Deciphera Pharmaceuticals Earnings Date, Estimates & Call Transcripts (2022)

$13.73

-0.25 (-1.79%)

(As of 06/24/2022 04:00 PM ET)

Add

Compare

Today's Range: $13.38
▼
$14.48
50-Day Range: $9.11
▼
$13.98
52-Week Range: $6.51
▼
$14.48

Volume: 2.22 million shs
Average Volume: 1.04 million shs
Market Capitalization: $909.20 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $26.57

Upcoming Earnings Date: Aug. 2Estimated
Actual EPS (May. 4): -$0.80 Beat By $0.03
Consensus EPS (May. 4): -$0.83
Last Year's Q2 EPS (5/4/2021): -$1.06

Read Call Transcript

Listen to Call

Latest SEC 10-Q Filing

Earnings Per Share Revenue

DCPH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DCPH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Deciphera Pharmaceuticals Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2022	4	($0.91)	($0.77)	($0.87)
Q2 2022	4	($0.76)	($0.55)	($0.67)
Q3 2022	4	($0.64)	($0.49)	($0.60)
Q4 2022	4	($0.63)	($0.46)	($0.56)
FY 2022	16	($2.94)	($2.27)	($2.71)
Q1 2023	1	($0.58)	($0.58)	($0.58)
Q2 2023	1	($0.60)	($0.60)	($0.60)
Q3 2023	1	($0.57)	($0.57)	($0.57)
Q4 2023	1	($0.58)	($0.58)	($0.58)
FY 2023	4	($2.33)	($2.33)	($2.33)

DCPH Earnings Date and Information

Deciphera Pharmaceuticals last posted its quarterly earnings results on May 4th, 2022. The reported ($0.80) EPS for the quarter, beating the consensus estimate of ($0.83) by $0.03. The business earned $29.22 million during the quarter, compared to the consensus estimate of $27.17 million. Its quarterly revenue was up 16.2% on a year-over-year basis. Deciphera Pharmaceuticals has generated ($4.89) earnings per share over the last year (($4.89) diluted earnings per share). Earnings for Deciphera Pharmaceuticals are expected to grow in the coming year, from ($2.62) to ($1.70) per share. Deciphera Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 2nd, 2022 based off prior year's report dates.

Deciphera Pharmaceuticals Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/2/2022 (Estimated)
5/4/2022	3/31/2022	($0.83)	($0.80)	+$0.03		$27.17 million	$29.22 million
2/8/2022	Q4 2021	($1.49)	($1.51)	($0.02)	($1.51)	$23.28 million	$24.20 million
11/2/2021	9/30/2021	($1.29)	($1.37)	($0.08)	($1.37)	$23.73 million	$23.22 million
8/3/2021	6/30/2021	($1.15)	($1.21)	($0.06)	($1.21)	$22.25 million	$23.57 million
5/4/2021	3/31/2021	($1.08)	($1.06)	+$0.02	($1.06)	$21.35 million	$25.16 million
2/8/2021	12/31/2020	($1.16)	($1.10)	+$0.06	($1.10)	$18.68 million	$19.49 million
11/5/2020	9/30/2020	($1.32)	($1.13)	+$0.19	($1.13)	$6.73 million	$15.45 million
8/4/2020	6/30/2020	($1.34)	($1.20)	+$0.14	($1.20)	$2.03 million	$7.09 million
5/5/2020	3/31/2020	($1.28)	($1.36)	($0.08)	($1.36)	$2.50 million	$0.06 million
3/9/2020	12/31/2019	($1.13)	($1.31)	($0.18)	($1.31)	$7.50 million
11/4/2019	Q3	($1.19)	($1.28)	($0.09)	($1.28)	$5.00 million
8/2/2019	Q2 2019	($1.1240)	($0.56)	+$0.5640	($0.56)	$20.00 million	$25.00 million
5/9/2019	Q1	($0.8410)	($1.25)	($0.4090)	($1.25)
3/14/2019	Q4	($0.7340)	($0.86)	($0.1260)	($0.86)
11/8/2018	9/30/2018	($0.65)	($0.65)		($0.65)
8/7/2018	Q2 2018	($0.6780)	($0.65)	+$0.0280	($0.65)
5/8/2018	Q1 2018	($0.62)	($0.66)	($0.04)	($0.66)
3/28/2018	Q4 2017	($0.4270)	($0.62)	($0.1930)	($0.62)
11/14/2017	Q3 2017	($0.5450)	($5.85)	($5.3050)	($5.85)

Deciphera Pharmaceuticals Earnings - Frequently Asked Questions

When is Deciphera Pharmaceuticals's earnings date?: Deciphera Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 2nd, 2022 based off last year's report dates. Learn more on DCPH's earnings history.
Did Deciphera Pharmaceuticals beat their earnings estimates last quarter?: In the previous quarter, Deciphera Pharmaceuticals (NASDAQ:DCPH) reported ($0.80) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.83) by $0.03. Learn more on analysts' earnings estimate vs. DCPH's actual earnings.
How can I listen to Deciphera Pharmaceuticals's earnings conference call?: The conference call for Deciphera Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call
How can I read Deciphera Pharmaceuticals's conference call transcript?: The conference call transcript for Deciphera Pharmaceuticals's latest earnings report can be read online. Read Transcript
How can I view Deciphera Pharmaceuticals's earnings report?: Deciphera Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Deciphera Pharmaceuticals generate each year?: Deciphera Pharmaceuticals (NASDAQ:DCPH) has a recorded annual revenue of $96.15 million.
How much profit does Deciphera Pharmaceuticals generate each year?: Deciphera Pharmaceuticals (NASDAQ:DCPH) has a recorded net income of -$299.96 million. DCPH has generated -$4.89 earnings per share over the last four quarters.
What is Deciphera Pharmaceuticals's EPS forecast for next year?: Deciphera Pharmaceuticals's earnings are expected to grow from ($2.62) per share to ($1.70) per share in the next year.

This page (NASDAQ:DCPH) was last updated on 6/26/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources